Literature DB >> 22327815

Causes of thrombocytopenia in chronic hepatitis C viral infection.

Makoto Osada1, Makoto Kaneko, Minoru Sakamoto, Masumi Endoh, Koichi Takigawa, Katsue Suzuki-Inoue, Osamu Inoue, Kaneo Satoh, Nobuyuki Enomoto, Yutaka Yatomi, Yukio Ozaki.   

Abstract

We retrospectively studied 89 patients with chronic hepatitis C virus (HCV) infection, including 50 chronic hepatitis (CH) cases, 18 liver cirrhosis (LC) cases, and 21 LC with hepatocellular carcinoma (LC + HCC) cases, with regard to various factors related with thrombocytopenia. The platelet count decreased with the stage advancement of liver diseases. Multiple regression analysis revealed that splenomegaly and von Willebrand factor (vWF) were explanatory variables that correlated with thrombocytopenia. Splenomegaly appears to be the most responsible factor, although there are a considerable number of thrombocytopenic cases without splenomegaly, suggesting other factors may also be responsible. The vWF level is inversely correlated with the platelet count. Soluble thrombomodulin, a marker of endothelial dysfunction, increases with the advancement of liver fibrosis. It is positively correlated with vWF and inversely with the platelet count. Our present results imply that vascular endothelial dysfunction is also involved in thrombocytopenia during chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327815     DOI: 10.1177/1076029611429124

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  8 in total

1.  Factors associated with the platelet count in patients with chronic hepatitis C.

Authors:  Michele M Tana; Xiongce Zhao; Alyson Bradshaw; Mi Sun Moon; Sandy Page; Tiffany Turner; Elenita Rivera; David E Kleiner; Theo Heller
Journal:  Thromb Res       Date:  2015-02-19       Impact factor: 3.944

2.  Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

Authors:  Milka Koupenova; Olga Vitseva; Christopher R MacKay; Lea M Beaulieu; Emelia J Benjamin; Eric Mick; Evelyn A Kurt-Jones; Katya Ravid; Jane E Freedman
Journal:  Blood       Date:  2014-04-22       Impact factor: 22.113

3.  A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation.

Authors:  Liting Wen; Shuping Weng; Chuan Yan; Rongping Ye; Yuemin Zhu; Lili Zhou; Lanmei Gao; Yueming Li
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

4.  Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin.

Authors:  Tatsuo Miyamura; Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Xia Jiang; Makoto Arai; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
Journal:  Viruses       Date:  2012-08-14       Impact factor: 5.048

Review 5.  Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection.

Authors:  Shiksha Kedia; Vijaya Raj Bhatt; Sandeep Kumar Rajan; Pavan Kumar Tandra; Radwa A El Behery; Mojtaba Akhtari
Journal:  Int J Prev Med       Date:  2014-12

Review 6.  Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection.

Authors:  Sumit Dahal; Smrity Upadhyay; Rashmi Banjade; Prajwal Dhakal; Nabin Khanal; Vijaya Raj Bhatt
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-03-01       Impact factor: 2.576

7.  Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C.

Authors:  Baek Gyu Jun; Eui Ju Park; Woong Cheul Lee; Jae Young Jang; Soung Won Jeong; Young Don Kim; Gab Jin Cheon; Young Sin Cho; Sae Hwan Lee; Hong Soo Kim; Yun Nah Lee; Sang Gyune Kim; Young Seok Kim; Boo Sung Kim
Journal:  Korean J Intern Med       Date:  2018-03-14       Impact factor: 2.884

8.  Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease.

Authors:  Mahmoud Saif-Al-Islam; Usama M Abdelaal; Mustafa Adel Younis; Hisham A Alghany Algahlan; Safaa Khalaf
Journal:  Gastroenterol Res Pract       Date:  2021-05-23       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.